Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal erythrocyte morphology (HP:0001877)help
Parent Node:
expand
Abnormal hemoglobin (HP:0011902)help
..Starting node
..expand
Elevated hemoglobin A1c (HP:0040217)help
Term ID: 40217
Name: Elevated hemoglobin A1c
Synonym: Elevated glycated haemoglobin; Elevated glycated hemoglobin; Elevated glycosylated haemoglobin; Elevated glycosylated hemoglobin; Elevated haemoglobin A1c; Elevated HbA1c; Increased HbA1c levels
Definition: An increased concentration of hemoglobin A1c (HbA1c), which is the product of nonenzymatic attachment of a hexose molecule to the N-terminal amino acid of the hemoglobin molecule. This reaction is dependent on blood glucose concentration, and therefore reflects the mean glucose concentration over the previous 8 to 12 weeks. The HbA1c level provides a better indication of long-term glycemic control than one-time blood or urinary glucose measurements.
Comments:
Reference: HP:0040217
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandAbnormal mean corpuscular hemoglobin concentration (HP:0025546) help
..expandHbH hemoglobin (HP:0011903) help
..expandHbS hemoglobin (HP:0045047) help
..expandHemoglobin Barts (HP:0005507) help
..expandImbalanced hemoglobin synthesis (HP:0005560) help
..expandIncreased HbA2 hemoglobin (HP:0045048) help
..expandMethemoglobinemia (HP:0012119) help
..expandPersistence of hemoglobin F (HP:0011904) help
..expandReduced hemoglobin A (HP:0011905) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0040217HP:0040217Elevated hemoglobin A1c0ABCC8 CL E G H683359ORPHA:79134DEND syndromeHP:0040281 - Very frequent245
HP:0040217HP:0040217Elevated hemoglobin A1c0ABCC8 CL E G H683359ORPHA:552MODYHP:0040282 - Frequent245
HP:0040217HP:0040217Elevated hemoglobin A1c0APPL1 CL E G H2606024035ORPHA:552MODYHP:0040282 - Frequent2
HP:0040217HP:0040217Elevated hemoglobin A1c0BLK CL E G H6401057ORPHA:552MODYHP:0040282 - Frequent75
HP:0040217HP:0040217Elevated hemoglobin A1c0BLM CL E G H6411058OMIM:210900Bloom syndrome314
HP:0040217HP:0040217Elevated hemoglobin A1c0BSCL2 CL E G H2658015832OMIM:269700Lipodystrophy, congenital generalized, type 2105
HP:0040217HP:0040217Elevated hemoglobin A1c0CEL CL E G H10561848ORPHA:552MODYHP:0040282 - Frequent25
HP:0040217HP:0040217Elevated hemoglobin A1c0CELA2A CL E G H6303624609OMIM:618620ABDOMINAL OBESITY-METABOLIC SYNDROME 4; AOMS41
HP:0040217HP:0040217Elevated hemoglobin A1c0DNAJC3 CL E G H56119439OMIM:616192Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus3
HP:0040217HP:0040217Elevated hemoglobin A1c0GCK CL E G H26454195OMIM:606176DIABETES MELLITUS, PERMANENT NEONATAL; PNDM237
HP:0040217HP:0040217Elevated hemoglobin A1c0GCK CL E G H26454195ORPHA:552MODYHP:0040282 - Frequent237
HP:0040217HP:0040217Elevated hemoglobin A1c0HNF1A CL E G H692711621ORPHA:552MODYHP:0040282 - Frequent161
HP:0040217HP:0040217Elevated hemoglobin A1c0HNF4A CL E G H31725024ORPHA:552MODYHP:0040282 - Frequent138
HP:0040217HP:0040217Elevated hemoglobin A1c0INS CL E G H36306081OMIM:618858DIABETES MELLITUS, PERMANENT NEONATAL, 4; PNDM462
HP:0040217HP:0040217Elevated hemoglobin A1c0INS CL E G H36306081ORPHA:552MODYHP:0040282 - Frequent62
HP:0040217HP:0040217Elevated hemoglobin A1c0KCNJ11 CL E G H37676257ORPHA:79134DEND syndromeHP:0040281 - Very frequent127
HP:0040217HP:0040217Elevated hemoglobin A1c0KCNJ11 CL E G H37676257OMIM:610582Diabetes mellitus, transient neonatal, 3.127
HP:0040217HP:0040217Elevated hemoglobin A1c0KCNJ11 CL E G H37676257ORPHA:552MODYHP:0040282 - Frequent127
HP:0040217HP:0040217Elevated hemoglobin A1c0KLF11 CL E G H846211811ORPHA:552MODYHP:0040282 - Frequent78
HP:0040217HP:0040217Elevated hemoglobin A1c0MTX2 CL E G H106517506OMIM:619127MANDIBULOACRAL DYSPLASIA PROGEROID SYNDROME; MDPS
HP:0040217HP:0040217Elevated hemoglobin A1c0NARS2 CL E G H7973126274ORPHA:79134DEND syndromeHP:0040281 - Very frequent34
HP:0040217HP:0040217Elevated hemoglobin A1c0NEUROD1 CL E G H47607762ORPHA:552MODYHP:0040282 - Frequent32
HP:0040217HP:0040217Elevated hemoglobin A1c0NSMCE2 CL E G H28605326513OMIM:617253Seckel syndrome 10.2
HP:0040217HP:0040217Elevated hemoglobin A1c0PAX4 CL E G H50788618ORPHA:552MODYHP:0040282 - Frequent55
HP:0040217HP:0040217Elevated hemoglobin A1c0PDX1 CL E G H36516107ORPHA:552MODYHP:0040282 - Frequent30
HP:0040217HP:0040217Elevated hemoglobin A1c0TRMT5 CL E G H5757023141OMIM:616539Combined oxidative phosphorylation deficiency 264
HP:0040217HP:0040217Elevated hemoglobin A1c0WRN CL E G H748612791OMIM:277700Werner syndrome310
HP:0040217HP:0040217Elevated hemoglobin A1c0YIPF5 CL E G H8155524877OMIM:619278MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2; MEDS2


Genes (23) :ABCC8 APPL1 BLK BLM BSCL2 CEL CELA2A DNAJC3 GCK HNF1A HNF4A INS KCNJ11 KLF11 MTX2 NARS2 NEUROD1 NSMCE2 PAX4 PDX1 TRMT5 WRN YIPF5

Diseases (14) :ORPHA:79134 ORPHA:552 OMIM:210900 OMIM:269700 OMIM:618620 OMIM:616192 OMIM:606176 OMIM:618858 OMIM:610582 OMIM:619127 OMIM:617253 OMIM:616539 OMIM:277700 OMIM:619278
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.